Citation

Ahmad S, Madsen CS, Stein PD, Janovitz E, Huang C, Ngu K, Bisaha S, Kennedy LJ, Chen BC, Zhao R, Sitkoff D, Monshizadegan H, Yin X, Ryan CS, Zhang R, Giancarli M, Bird E, Chang M, Chen X, Setters R, Search D, Zhuang S, Nguyen-Tran V, Cuff CA, Harrity T, Darienzo CJ, Li T, Reeves RA, Blanar MA, Barrish JC, Zahler R, Robl JA.: (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential. J Med Chem, Volume 51 (9), 2008

Authors

Ahmad S, Bird E, Bisaha S, Chang M, Chen BC, Chen X, Cuff CA, Giancarli M, Huang C, Janovitz E, Kennedy LJ, Madsen CS, Monshizadegan H, Ngu K, Nguyen-Tran V, Ryan CS, Search D, Setters R, Sitkoff D, Stein PD, Yin X, Zhang R, Zhao R, Zhuang S, Barrish JC, Blanar MA, Darienzo CJ, Harrity T, Li T, Reeves RA, Robl JA., Zahler R

Journal

J Med Chem

Year

2008

DOI

10.1021/jm800001n

PubMed

18412317

Machine-readable

REST APIRDF